# OnCo record paper-radiant-4-everolimus-lancet-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-radiant-4-everolimus-lancet-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-radiant-4-everolimus-lancet-2016" ;
  schema:name "RADIANT-4: everolimus for advanced non-functional neuroendocrine tumours of the lung or gastrointestinal tract"@en ;
  schema:description "Everolimus more than doubled the time to progression in advanced non-functioning neuroendocrine tumours of the lung and gut, the first drug with randomised evidence in lung carcinoids."@en ;
  schema:url <https://onco.cc/key-papers/paper-radiant-4-everolimus-lancet-2016/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(15)00817-X>, <https://pubmed.ncbi.nlm.nih.gov/26703889/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(15)00817-X> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Yao JC, Fazio N, Singh S, et al." ;
  onco:cancers <https://onco.cc/cancers/lung-net/>, <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:drugs <https://onco.cc/drugs/everolimus/> ;
  onco:journals <https://onco.cc/journals/lancet/> .
